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Abstract 
Objectives: The atrial appendages play a regulatory role in the fluid homeostasis and in the secretion of atrial natriuretic 
peptide (ANP). ANP is a 28-amino-acid peptide synthesized in the cardiac myocytes, where it is stored as a pro-hormone in 
cardiomyocyte granules. When released, it participates in cardiovascular volume and pressure homeostasis.
We hypothesized that patients with surgical closure of the Left Atrial Appendage (LAA) – would have lower increase of Mid 
Region-pro-hormone ANP (MR-proANP) during exercise compared to patients with open LAA. Patients were randomized 
into two groups – one with surgical closure of the LAA during planned cardiac surgery and one with open LAA. 
Methods: A group of 19 patients who had undergone elective open heart surgery, and who had been randomized to either 
the LAA-closure group (n=9), or to the LAA-open group (n=10) performed a standard bicycle exercise test, at least six weeks 
after the operation. Closure of the LAA was confirmed by Transesophageal Echocardiography (TEE). Venous blood samples 
were collected before the test, and within the first two minutes of recovery after maximum work-load.
Results: Baseline ANP showed (non-closed vs. closed LAA): 163.3pM (95% CI: 121.9 – 204.8) vs. 137.5 pM (95% CI: 69.5 
– 205.6), p=0.4575.
Maximum work-load was similar for both groups. MR-proANP concentration rose significantly:
Max ANP (non-closed vs. closed LAA): 197.4pM (95% CI: 146.9 - 247.9) vs. 164.3pM (95% CI: 89.1 - 239.6), p=0.4061
MR-proANP increase was not different between the groups. 
Delta ANP (non-closed vs. closed LAA): 34.1pM (95% CI: 22.1 – 46.1) vs. 26.8pM (95% CI: 15.3 – 38.3), p=0.3352
Conclusion: This study shows that plasma MR-proANP increases during exercise, and that surgical LAA closure did not 
reduce the increase of MR-proANP in response to physical exercise. These findings indicate that other areas of the heart elicit 
most of the MR-proANP production
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During exercise circulating levels of ANP increase rap-
idly. After ending exercise ANP falls to pre-exercise values 
within 30 minutes [16]. Intriguingly, patients with heart failure 
and patients with ischemic heart disease experience a greater 
increase in plasma-ANP during exercise, which has been at-
tributed to predominance of ANP pre-secretory atrial stores 
[17,18]. 
We hypothesized that patients in the LAA – closure 
group, randomized to surgical closure of the LAA during 
planned surgery, would have lower increases of MR-proANP 
during exercise compared to the LAA-open group, as a sur-
rogate for ANP, due to its higher stability. 
 
Method
The patients where recruited from the department of 
Thoracic surgery at the Region of Copenhagen, Denmark, and 
offered to participate in the LAACS project (Left Atrial Ap-
pendage Closure with Surgery) protocol (ID NCT02378116, 
at ClinicalTrials.org). Patients were randomized to surgical 
closure of the LAA in addition to their planned open heart 
surgery; (the LAA-closure group) or control (the LAA-open 
group). The study was approved by Regional Ethics Committee 
of Capital Region Denmark. All patients have signed informed 
consent. Exclusion- and inclusion criteria for the LAACS trial 
are presented in table I. 
For the group of patients randomized to surgical clo-
sure, the surgeon closed the LAAs with a purse-string ligature 
secured with single stitches.
The main study aims to test whether surgical closure 
of the LAA protects the brain against thromboembolic events. 
The patients who accepted blood sample collection during an 
exercise test at least six weeks after surgery, provided the mate-
rial for this sub-study. The exercise test was performed with 
a standard ergo-meter bicycle (Ergo line GMBH cycle, with 
Spacelab Healthcare cardio navigator v.2.604) with increasing 
load according to current guidelines [19,20] The patients were 
asked to refrain from physical activities on the day of testing. 
After an initial physical examination, the patients rested 
for a minimum of 10 minutes, before collection of the first ve-
nous blood sample to determine resting levels of MR-proANP. 
A second blood sample was drawn within two minutes after 
reaching maximum tolerated exercise load.
We measured plasma MR-proANP as, unlike ANP, is 
well preserved in plasma [21] 
 For the measurements of plasma MR-proANP, we used 
an automated proANP immunoassay (BRAHMS, Hennigs-
dorf, Germany) with targeted epitopes in the mid-region of 
the precursor (MR-proANP) [22]. 
Selected results of the exercise test are listed in Table II. 
Introduction
In this paper we present measurements of MR-proANP 
levels during exercise tests on two groups of patients who un-
derwent open heart surgery, and who had been randomized 
to either having the Left Atrial Appendage (LAA) surgi-
cally closed as additional procedure or having it left open. 
Background
The Natriuretic Peptide System (NPS) is an endoge-
nous system consisting of natriuretic peptides, including atrial 
natriuretic peptide (ANP), brain-natriuretic peptide (BNP) 
and C-type natriuretic peptide (CNP) [1]. ANP is a 28-amino-
acid peptide synthesized in the atrial myocytes in response 
to atrial distension [1,2]. When synthesized ANP is stored 
in specific intracellular myocyte granules as a pro-hormone 
(pro-ANP) that undergoes final processing during release into 
the circulation, to yield the biologically active C-terminal and 
the inactive N-terminal fragment ANP [2]. N-terminal frag-
ment of pro-hormone-ANP (NT-pro-ANP) derives from the 
proteolysis of pro-ANP, where pro-ANP is released both as 
an active hormone and an inactive N-terminal fragment [1]. 
NT-proANP has a much longer half-life than mature ANP and 
has therefore been suggested to be a more reliable analyte for 
measurement than mature ANP [3].
An assay for NT-proANP has been developed, utilizing 
antibodies against the mid-region of the molecule, thus termed 
mid-regional pro-atrial natriuretic peptide (MR-proANP) [4].
ANP is believed to protect the cardiovascular system 
from volume and pressure overload through two major path-
ways; a vasodilatory effect and a renal effect [1,2,5].
ANP directly dilates veins, resulting in a decrease in 
central venous pressure and thereby decreasing ventricular 
pre-load. It also dilates arteries, resulting in a decrease in sys-
temic vascular resistance and arterial pressure. It increases 
glomerular filtration and decreases renin secretion, counter-
effecting the renin-angiotensin-aldosterone system, thereby 
acting as a diuretic [2,5,6] In addition, ANP has a cardio pro-
tective role by regulating cellular growth, cellular proliferation, 
and cardiac hypertrophy [7]. Under normal circumstances the 
myocytes in the atria and the ventricles in the human heart 
will produce ANP to regulate fluid homeostasis [8,9] but when 
the ventricles and atria in the heart are stretched, the synthesis 
of these peptides increases. ANP gene expression is increased 
in the ventricular myocardium of the failing heart proportion-
ally with the severity of congestive heart failure or ventricu-
lar haemodynamic overload [10]. Therefore resting levels of 
natriuretic peptides are higher in chronic heart failure and 
atrial fibrillation compared with normal [1,11,12].
ANP gene transcripts have been shown in both atrial 
and ventricular myocytes; however, the level of ventricular 
ANP transcription is generally lower than that found in the 
atria [1,9,13]. 
It has been reported that the most intensely staining 
granules are localized in the atrial appendages [13,14]. There is 
still a need for better mapping of the ANP producing areas,[8]
and it is claimed that 30 % of the ANP in the heart is contained 
in the LAA [15].
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Table I. Exclusion- and inclusion criteria for the LAACS trial. 
Inclusion criteria Exclusion criteria
Age > 18 years Off-pump heart surgery
Planned CABG Endocarditis
Planned valve surgery, alone or in combination with 
CABG
Patients with pacemaker or other metal implantations 
non- compatible with MRI
Planned implantation of pacemaker.
 
Table II. Results of exercise test grouped according to randomization.
 LAA-closure goup LAA-open group
Maximum heart rate, 
beats per minute mean, (SD)
127 (22) 121 (14) (p=0,53)
Start systolic blood 
pressure, mmHg, mean, 
(range),SD  
140 (153-119),10,04 135 (189-105), 25,64 
(p=0,59)
Max systolic blood 
pressure, mmHg, mean, 
(range),SD
198 (219-158), 22,75 190 (211-147), 21,52 
(p=0,46)
BORG scale mean, 
(SD)
17 (0,83) 16 (0,96)
Time to max, minutes 
mean (SD)
11 (4.17) 11 (3.55)
 
Statistics
In healthy persons, plasma concentration of natriu-
retic hormones increases by 50% under maximum tolerated 
workload on an bicycle ergometer [23]. Patients who have 
undergone open heart surgery experience a similar increase, 
although they have higher pre-test levels [24]. Variation on 
natriuretic hormone measurements in a population of pa-
tients with heart disease is about 20% [25] According to these 
studies, we calculated that we could detect a 30% difference 
between the two groups (with expected lower increase in the 
group randomized to closure of the LAA) by including 42 pa-
tients with 90% power and a 5% risk of type 2 error. With 80% 
power and the same significance level, according to the vari-
ation observed in MR-proANP measurements [22], we calcu-
lated that we needed to include eight patients in each group 
and we planned to include 10 patients in each group.
All data analyses were performed using SAS9.4 (Cary, 
NC). Continuous data are expressed as mean ±SD and cate-
gorical variables as proportions. After inspection for normal-
ity, between group differences were compared using the t-test, 
Mann–Whitney U test and Fisher’s exact test, as appropriate. 
For all hypothesis testing, a two-tailed p<0.05 was required for 
statistical significance.
 
 
Results
A total of 24 patients were included but five patients 
were not able to perform the test. One did not show up repeat-
edly to the appointments and four were too physically weak to 
perform the test. 
Accordingly, data from a total of 19 patients were ana-
lyzed in this study: Nine patients randomized to closure of the 
LAA and 10 randomized to the control group. Patient charac-
teristics are summarized in Table III. 
Exercise test was performed in average 589 ± 116 days 
after surgery for the group with open LAA and 545± 210 days 
for the group with closed LAA. No tests were done earlier than 
six weeks from surgery. 
There were no significant difference in the exercise ca-
pacity of the patients in the two groups (Table II). 
Plasma MR-proANP concentrations at baseline and 
after max workload for each individual in the two groups are 
depicted in figure 1 and can be seen in detail in Table III. 
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Table III. Patient characteristics and MR-pro-ANP levels.
age (years) sex Left 
Ventricle 
Ejection 
Fraction 
(%)
Left 
Atrium 
volume/
BSA (ml/
m2)*
beta-blok-
ker use
RAS 
blockade 
use
MR-pro-
ANP            
baseline           
(pM)
MR-pro-
ANP            
max. load  
(pM)
delta                           
MR-pro-
ANP (pM)
CON-
TROL
         
1 54 m 50 NA yes no 75 110 34
2 66 m 60 32.5 no no 118 135 17
3 61 m 55 33 yes yes 202 238 36
4 69 m 60 >40 yes yes 158 196 38
5 56 m 60 >40 yes no 263 311 48
6 80 f 55 NA yes no 245 312 68
7 66 m 60 NA yes no 130 146 16
8 76 m 60 32.2 yes yes 155 171 16
9 74 m 60 NA yes no 159 203 44
10 73 m 45 NA yes yes 130 154 24
CLOSED 
LAA
         
1 76 f 60 32.3 no yes 160 219 59
2 53 m 50 27.9 yes no 54 77 23
3 70 m 35 34.4 yes yes 262 290 28
4 55 f 60 NA yes yes 90 110 20
5 72 m 60 28 no yes 110 125 14
6 70 m 55 NA yes no 306 349 43
7 75 f 50 NA no no 94 112 18
8 64 m 45 37.6 yes yes 72 91 19
9 74 m 50 28 no no 90 106 16
p-values 0,96 0,14 0,08 0,10 0,52 0,46 0,41 0,32
Figure 1. “MR-ProANP during exercise test”
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We hypothesized that the MR-proANP levels in the 
LAA-closure group would not rise as much as the LAA-open 
group. Our findings indicate that this is not the case, and that 
other areas of the heart may have important ANP secreting 
properties. 
Even though LAA is thought to play a central role in 
MR-proANP release, [7,8] studies using immunohistochemi-
cally techniques have demonstrated a greater number of in-
tensely granulated cardiomyocytes secreting MR-proANP in 
the right rather than in the left atrium [9]. If the myocytes out-
side the LAA produce most of the MR-proANP, it can be dif-
ficult to measure the impact of LAA closure on MR-proANP 
levels, thereby explaining our results. Older experimental 
studies on rats seem to support this dominant role of the right 
atrial appendage [26]. 
In humans, Omari et al. examined the effect of right 
atrial appendage removal during cardiac surgery, in patients 
with normal systolic function and concluded that preserving 
the right atrial appendage during cardiac operations signifi-
cantly increased the release of atrial natriuretic hormone [27].
Baseline ANP showed (non-closed vs. closed LAA): 
163.3pM (95% CI: 121.9 – 204.8) vs. 137.5 pM (95% CI: 69.5 
– 205.6), p=0.4575.
Maximum work-load was similar for both groups. MR-
proANP concentration rose significantly:
Max ANP (non-closed vs. closed LAA): 197.4 pM (95% 
CI: 146.9 - 247.9) vs. 164.3 pM (95% CI: 89.1 - 239.6), p=0.4061
MR-proANP increase was not different between the 
groups. 
Delta ANP (non-closed vs. closed LAA): 34.1 pM (95% 
CI: 22.1 – 46.1) vs. 26.8 pM (95% CI: 15.3 – 38.3), p=0.3352
We made a sub analysis where we excluded a total of 
two patients with low ejection fraction (EF) and AF, which are 
known to give higher ANP levels. 
 
Sub-analysis (excluding one patient with low EF and one pa-
tient with permanent AF):
Baseline ANP (non-closed vs. closed LAA): 163.3 pM 
(95% CI: 121.9 - 204.8) vs. 95.7 pM (95% CI: 64.7 - 126.7), 
p=0.0144
Max ANP (non-closed vs. closed LAA): 197.4 pM (95% 
CI: 146.9 - 247.9) vs. 120.0 pM (95% CI: 77.1 - 162.9), p=0.0229
Delta ANP (non-closed vs. closed LAA): 34.1 pM (95% 
CI: 22.1 – 46.1) vs. 24.3 pM (95% CI: 9.8 - 38.8), p=0.2403
Discussion
Two patients in the LAA-closure group had particu-
larly elevated MR-proANP measurements. Trans-esophageal 
echocardiography demonstrated completely closed LAA in 
both patients, but they differed from the rest of the cohort as 
one of them was the only one with heart failure (EF 35%) and 
the other was the only patient in the cohort with permanent 
Atrial Fibrillation (AF). If we exclude these two patients in 
a sub-analysis, the LAA-open group had significantly higher 
pre-test MR-proANP levels (163.3 pM SD 54.95) compared to 
the group with closed LAA (95.7 pM, SD 42.94), p=0.0144, 
and significantly higher max ANP (non-closed vs. closed 
LAA): 197.4 pM (95% CI: 146.9 - 247.9) vs. 120.0 pM (95% CI: 
77.1 - 162.9), p=0.0229.
Increase during exercise did not differ between the 
two groups 34.1% (SD 10.37) in the group with open LAA 
compared to 24.3% (SD 11.01) in the group with closed LAA, 
p=0.24.
Both hearth failure and AF are known to increase the 
levels of MR-proANP [12,11]. The only patient in the cohort 
with permanent AF had the highest levels of MR-proANP.
Possible clinical implications of affection of the ANP 
levels, especially if lower resting levels, could be disturbances 
in the blood pressure and electrolyte homeostasis, the areas 
mostly affected by ANP [5]. A study from 1998 looked at pa-
tients having Maze surgery. Maze procedure was performed in 
open heart surgery in order to treat AF and consists of surgi-
cal amputation of the LAA and the right atrial appendage and 
ablation of the pulmonary veins. This procedure is not com-
monly done in today’s surgery and has largely been replaced 
by radio frequency ablation (RFA) together with LAA closure, 
where the right atrial appendage is left untreated. 
A group of patients having maze surgery were com-
pared with a control group. There was a tendency to fluid 
retention in the maze group and a significantly greater doses 
of furosemide and dopamine were administered to the maze 
group and the response of ANP secretion by exercise was sig-
nificantly attenuated in the maze group (n = 12) compared 
with the non-maze group (n = 9) [28]. It has not been reported 
that patients with LAA closure have had problems with fluid 
retention and needing additional furosemide treatment. It 
is important to notice that the right atrial appendage in our 
cohort has been left untreated, furthermore supporting that 
the right atrial appendage is an area of importance involved in 
ANP production. Studies using immunohistochemically tech-
niques have also demonstrated a greater number of intensely 
granulated cardiomyocytes secreting MR-proANP in the right 
rather than in the left atrium [9].
Much larger scale studies are needed to answer this 
question. We find this relevant to examine in future studies 
in regards to the safety of the LAA-closure which is becoming 
more and more common. Still we believe that the benefits of 
protection from stroke from closure of the LAA would by far 
surpass possible disturbances in the ANP levels.
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The main strength of our study is that we had a unique 
opportunity to compare the effect of surgical closure of the 
LAA on MR-proANP circulating levels in a randomized study 
in humans. Our results could be explained by a more promi-
nent role of the right atrium on MR-proANP changes during 
hemodynamic challenges, which could be addressed in future 
studies. 
In a recently published study, Cruz Gonzales et al. [29] 
found a significant decrease in resting levels of BNP 45-60 
days after device implantation for closure of the LAA. Unfor-
tunately, we did not perform pre- surgery measurements of 
MR-proANP. Hence, we cannot discard that resting level dif-
ferences could have been apparent before surgery in patients 
with conditions of volume overload where the diuretic effects 
of ANP are activated in the LAA, such as in heart failure. Fur-
thermore, it is probable that other areas of the heart are able to 
“compensate” when the LAA is closed.
 
Conclusion 
In our study, surgical LAA closure did not reduce the 
increase of MR-proANP in response to physical exercise, in-
dicating that other areas of the heart elicit most of the MR-
proANP production.
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